Guided Therapeutics (GTHP) Non-Current Assets (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly Non-Current Assets came in at $668000.0 in Q2 2026, up 417.83% year-over-year from $129000.0 in Q2 2025, and down 3.61% quarter-over-quarter from $693000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Non-Current Assets (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Non-Current Assets across 17 years of filings, most recently posting $668000.0 for Q2 2026.
- In Q2 2026, Non-Current Assets rose 417.83% year-over-year to $668000.0; the TTM figure through Jun 2026 stood at $668000.0 (up 417.83% YoY), while the FY2025 annual figure was $719000.0, up 297.24% from the prior year.
- Non-Current Assets came in at $668000.0 for Q2 2026 at Guided Therapeutics, down from $693000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $719000.0 in Q4 2025 to a low of $104000.0 in Q3 2025.
- Average Non-Current Assets over 5 years is $339888.9, with a median of $309000.0 recorded in 2023.
- Year-over-year, Non-Current Assets plunged 49.51% in 2025 and soared 417.83% in 2026.
- Over 5 years, Non-Current Assets stood at $362000.0 in 2022, then retreated by 23.76% to $276000.0 in 2023, then tumbled by 34.42% to $181000.0 in 2024, then soared by 297.24% to $719000.0 in 2025, then dropped by 7.09% to $668000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $668000.0 in Q2 2026, $693000.0 in Q1 2026, and $719000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | 668,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 668,000.00 |
| Mar 31, 2026 | 693,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Sep 30, 2024 | 206,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Mar 31, 2023 | 342,000.00 |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 403,000.00 |
| Sep 30, 2021 | 416,000.00 |